Medical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; medical diagnostic reagents consisting primarily of reagents for use in disease testing and prediction; nucleic acid sequences and chemical reagents for medical purposes

Business consulting services in the nature of evaluating and rating of pre-market pharmaceutical products for commercial purposes; business consulting services in the nature of evaluating and rating intellectual property in the field of pharmacology and biotechnology for commercial purposes